| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/06/2010 | US20100113796 Indole derivatives as s1p1 receptor |
| 05/06/2010 | US20100113755 Isolated modified human chorionic gonadotropin proteins |
| 05/06/2010 | US20100113602 Use of histone deacetylase inhibitors for the treatment of central nervous system metastases |
| 05/06/2010 | US20100113599 Amphipathic carboxylates for the treatment of immune-related disorders |
| 05/06/2010 | US20100113592 Unsymmetrical aromatic ether diacids and absorbable polymers therefrom |
| 05/06/2010 | US20100113590 Adam inhibitor |
| 05/06/2010 | US20100113587 use of abscissic acid to treat various diseases, including neurodegenerative and neuromuscular diseases |
| 05/06/2010 | US20100113575 Method for detecting autoprocessed, secreted pcsk9 |
| 05/06/2010 | US20100113573 Modulation of hif1 beta expression |
| 05/06/2010 | US20100113572 Photoreactive ru (ii) complexes anchored on oligonucleotides, method for obtaining them and use thereof |
| 05/06/2010 | US20100113567 Recombinant VSV For The Treatment of Tumor Cells |
| 05/06/2010 | US20100113561 Microrna molecules |
| 05/06/2010 | US20100113560 Compositions and methods for treating hematopoietic malignancies |
| 05/06/2010 | US20100113558 Compounds and methods |
| 05/06/2010 | US20100113557 Method for prevention of tumor |
| 05/06/2010 | US20100113549 Pyrrolidine compounds |
| 05/06/2010 | US20100113547 Novel imidazolidine compounds as androgen receptor modulators |
| 05/06/2010 | US20100113546 Imidazol-4-one and Imidazole-4-thione Compounds |
| 05/06/2010 | US20100113542 Triazole derivative as an hsp 90 inhibitor |
| 05/06/2010 | US20100113541 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 05/06/2010 | US20100113533 Polymorph II of 4-[4-(Amino)-3- Fluorophenoxy]-N-Methylpyridine-2-Carboxamide |
| 05/06/2010 | US20100113531 Thiazolidine derivatives as orexin receptor antagonists |
| 05/06/2010 | US20100113528 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists |
| 05/06/2010 | US20100113505 Amino-naphthyridine derivatives |
| 05/06/2010 | US20100113504 Amide compounds and their use as antitumor agents |
| 05/06/2010 | US20100113498 Novel vinblastine derivatives, their preparation, use and pharmaceutical compositions comprising the said derivatives |
| 05/06/2010 | US20100113485 Piperidinylamino-thieno[2,3-D] Pyrimidine Compounds |
| 05/06/2010 | US20100113476 Chemical linkers with single amino acids and conjugates thereof |
| 05/06/2010 | US20100113474 Antineoplastic Combinations of 4-Anilino-3-Cyanoquinolines and Capecitabine |
| 05/06/2010 | US20100113473 Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor |
| 05/06/2010 | US20100113472 Compounds for the treatment of osteoporosis and cancers |
| 05/06/2010 | US20100113471 2-Aminoaryloxazole compounds as tyrosine kinase inhibitors |
| 05/06/2010 | US20100113468 Quinazoline derivatives as kinase inhibitors |
| 05/06/2010 | US20100113467 Organic Compounds |
| 05/06/2010 | US20100113466 Oxazole-pyridazine-oxazole alpha-helix mimetic |
| 05/06/2010 | US20100113463 PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
| 05/06/2010 | US20100113459 Gene Polymorphisms as Predictors of Tumor Progression and Their Use in Cancer Therapy |
| 05/06/2010 | US20100113447 Triazole compounds that modulate hsp90 activity |
| 05/06/2010 | US20100113445 Chemical Compounds |
| 05/06/2010 | US20100113442 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
| 05/06/2010 | US20100113436 Dispiro tetraoxane compounds and their use in the treatment of malaria and/or cancer |
| 05/06/2010 | US20100113425 Pyrrolobenzodiazepines |
| 05/06/2010 | US20100113418 Heterocyclic compound |
| 05/06/2010 | US20100113414 Thiazolyl-dihydro-indazoles |
| 05/06/2010 | US20100113413 MAPK/ERK Kinase Inhibitors |
| 05/06/2010 | US20100113410 Pyrazolopyrimidine derivative |
| 05/06/2010 | US20100113404 Anti-angiogenic activity of 2-methoxyestradiol analogs in combination with anti-cancer agents |
| 05/06/2010 | US20100113392 Methods of using saha and bortezomib for treating multiple myeloma |
| 05/06/2010 | US20100113388 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
| 05/06/2010 | US20100113378 Compositions and Methods for Treating and Preventing Cancer Using Analogs of Vitamin D |
| 05/06/2010 | US20100113367 Peptide-cytotoxic conjugates |
| 05/06/2010 | US20100113366 Use of proline-rich peptide derived from hypothalamus for the manufacture of a medicament for the treatment and/or prophylaxis of cattle leucosis |
| 05/06/2010 | US20100113355 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 05/06/2010 | US20100113350 Methods and compositions for modulating prostasin |
| 05/06/2010 | US20100113341 Methods of using corticotropin-releasing factor for the treatment of cancer |
| 05/06/2010 | US20100113337 Method for reducing incidence or rate of development of skin cancers and related conditions |
| 05/06/2010 | US20100113335 Compositions and methods for treatement of cancer |
| 05/06/2010 | US20100113331 Substituted Imidazole Derivatives, Compositions, and Methods of Use as PtPase Inhibitors |
| 05/06/2010 | US20100113328 Targeted delivery to legumain-expressing cells |
| 05/06/2010 | US20100113326 Dimeric iap inhibitors |
| 05/06/2010 | US20100112685 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities |
| 05/06/2010 | US20100112634 Yeast strains autonomously producing steroids |
| 05/06/2010 | US20100112108 Extracts of Aristolochia Longa pomer and uses thereof |
| 05/06/2010 | US20100112102 Therapeutic compositions for the treatment of benigh prostate hyperplasia, prostatitis, impotence, infertility and prostate cancer and a method for the use thereof |
| 05/06/2010 | US20100112097 Pharmaceutical composition for preventing and treating cancer and health food containing the same for preventing and treating cancer |
| 05/06/2010 | US20100112090 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 05/06/2010 | US20100112089 Peptide compound and use thereof |
| 05/06/2010 | US20100112087 Oxygen-generating compositions for enhancing cell and tissue survival in vivo |
| 05/06/2010 | US20100112077 Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer |
| 05/06/2010 | US20100112076 Gellan-Gum Nanoparticles and Methods of Making and Using the Same |
| 05/06/2010 | US20100112071 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
| 05/06/2010 | US20100112046 Formulations of suberoylanilide hydroxamic acid and methods for producing same |
| 05/06/2010 | US20100112042 Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics |
| 05/06/2010 | US20100112041 Endoxifen Compositions And Methods |
| 05/06/2010 | US20100112040 Preparation of Heavy Metal-Containing Nano-Liposomes and their Uses in Medical Therapy |
| 05/06/2010 | US20100112039 Lornafarnib in combination with a taxane selected from paclitaxel and docetaxel, and also carboplatin, cisplatin or oxaliplatin |
| 05/06/2010 | US20100112026 Surfaces, methods and devices employing cell rolling |
| 05/06/2010 | US20100112011 Photodynamic therapy-generated mesothelioma vaccine |
| 05/06/2010 | US20100112003 Bifidobacterium in the treatment of inflammatory disease |
| 05/06/2010 | US20100111995 Antigen conjugates and uses thereof |
| 05/06/2010 | US20100111993 Recombinant vaccines and use thereof |
| 05/06/2010 | US20100111991 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 05/06/2010 | US20100111988 Small peptide for anti-angiogenesis and use thereof |
| 05/06/2010 | US20100111987 Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject |
| 05/06/2010 | US20100111978 Conjugates between a variant staphylococcal enterotoxin e superantigen and a targeting antibody that binds to a cancer-associated cell surface structure |
| 05/06/2010 | US20100111975 Monoclonal Antibodies for Treatment of Cancer |
| 05/06/2010 | US20100111973 Methods for treating mica-related disorders |
| 05/06/2010 | US20100111968 Methods for Mediating Fibrotic Response |
| 05/06/2010 | US20100111965 Combination therapy |
| 05/06/2010 | US20100111964 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 05/06/2010 | US20100111958 Notch-Binding Agents and Antagonists and Methods of Use Thereof |
| 05/06/2010 | US20100111956 antigen polypeptide for the diagnosis and/or treatment of ovarian cancer |
| 05/06/2010 | US20100111955 Hedgehog signaling pathway proteins and uses thereof |
| 05/06/2010 | US20100111951 ADAM-9 Modulators |
| 05/06/2010 | US20100111949 Methods and compositions for the treatment of proliferative diseases |
| 05/06/2010 | US20100111947 Pharmaceutical composition comprising antibody composition which specifically binds to ganglioside gm2 |
| 05/06/2010 | US20100111945 Novel uses |
| 05/06/2010 | US20100111944 Method of diagnosing, classifying and treating endometrial cancer and precancer |
| 05/06/2010 | US20100111941 Methods for treating cancer |
| 05/06/2010 | US20100111938 Compositions and methods for biological remodeling with frozen particle compositions |